Seeking Alpha

The FDA accepts Merck's (MRK) resubmission of a New Drug Application for its sugammadex sodium...

The FDA accepts Merck's (MRK) resubmission of a New Drug Application for its sugammadex sodium injection, which is used as a muscle relaxant during surgery. The FDA rejected the original NDA for sugammadex in 2008 and asked for additional information about allergic reactions and bleeding. (PR)
From other sites
Comments (1)
  • biochemist
    , contributor
    Comments (560) | Send Message
     
    Actually sugammadex is not a muscle relaxant. It is the first selective relaxant binding agent indicated to reverse the neuromuscular blockade induced during general anaesthesia. It blocks the action of rocuronium, which is a muscle relaxant.
    7 Jan 2013, 05:18 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs